Initially, research predominantly centered on VEGF and its corresponding receptor signaling pathways; however, it has since broadened to encompass advanced topics such as tumor microenvironment modulation, biomarker-guided therapies, and combination strategies that integrate immunotherapy with nanotechnology-based drug delivery systems. Here, VEGFA is linked to neoplasm.